Experimental Cancer Cachexia Changes Neuron Numbers and Peptide Levels in the Intestine: Partial Protective Effects after Dietary Supplementation with L-Glutamine

PLoS One. 2016 Sep 16;11(9):e0162998. doi: 10.1371/journal.pone.0162998. eCollection 2016.

Abstract

Gastrointestinal dysmotility frequently occurs in cancer cachexia and may result from damage to enteric innervation caused by oxidative stress, especially due to glutathione depletion. We assessed the effect of dietary supplementation with 20 g/kg l-glutamine (a glutathione precursor) on the intrinsic innervation of the enteric nervous system in healthy and Walker 256 tumor-bearing Wistar rats during the development of experimental cachexia (14 days), in comparison with non-supplemented rats, by using immunohistochemical methods and Western blotting. The total neural population and cholinergic subpopulation densities in the myenteric plexus, as well as the total population and VIPergic subpopulation in the submucosal plexus of the jejunum and ileum, were reduced in cachectic rats, resulting in adaptive morphometric alterations and an increase in vasoactive intestinal peptide (VIP) and calcitonin gene-related peptide (CGRP) expression, suggesting a neuroplastic response. l-glutamine supplementation prevented decrease in myenteric neuronal density in the ileum, morphometric alterations in the neurons and nerve fibers (in both the plexuses of the jejunum and ileum), and the overexpression of VIP and CGRP. Cancer cachexia severely affected the intrinsic innervation of the jejunum and ileum to various degrees and this injury seems to be associated with adaptive neural plasticity. l-glutamine supplementation presented partial protective effects on the enteric innervation against cancer cachexia, possibly by attenuating oxidative stress.

MeSH terms

  • Cachexia / complications*
  • Cachexia / pathology
  • Cell Line, Tumor
  • Dietary Supplements*
  • Glutamine / administration & dosage*
  • Humans
  • Intestinal Mucosa / metabolism*
  • Neoplasms / complications*
  • Neoplasms / pathology
  • Neurons / pathology*

Substances

  • Glutamine

Grants and funding

The project was funded by a grant from the Fundação Araucária (Apoio ao desenvolvimento Científico e Tecnológico do Paraná) - 266/14, and from the CNPq (Conselho Nacional de Desenvolvimento Científico e Tecnológico), Brazil to JNZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.